News

Net loss of Trident Texofab reported to Rs 2.01 crore in the quarter ended March 2026 as against net profit of Rs 0.51 crore during the previous quarter ended March 2025. Sales declined 12.14% to Rs 33.57 crore in the quarter ended March 2026 as against Rs 38.21 crore during the previous quarter ended March 2025.For the full year,net profit declined 72.11% to Rs 0.70 crore in the year ended March 2026 as against Rs 2.51 crore during the previous year ended March 2025. Sales declined 3.31% to Rs 118.02 crore in the year ended March 2026 as against Rs 122.06 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales33.5738.21 -12 118.02122.06 -3 OPM %-3.223.53 -4.334.49 - PBDT-0.920.84 PL 4.024.23 -5 PBT-1.300.43 PL 2.412.58 -7 NP-2.010.51 PL 0.702.51 -72 Powered by Capital Market - Live News

Trident Texofab has adjourned the meeting of the Board of Directors which was scheduled to be held on 28 May 2026. The meeting will now be held on 30 May 2026.

Trident Texofab will hold a meeting of the Board of Directors of the Company on 28 May 2026.

Net profit of Trident Texofab rose 90.00% to Rs 0.57 crore in the quarter ended December 2025 as against Rs 0.30 crore during the previous quarter ended December 2024. Sales declined 18.78% to Rs 25.74 crore in the quarter ended December 2025 as against Rs 31.69 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales25.7431.69 -19 OPM %6.377.29 - PBDT1.250.68 84 PBT0.840.27 211 NP0.570.30 90 Powered by Capital Market - Live News

Trident Texofab will hold a meeting of the Board of Directors of the Company on 12 February 2026.Powered by Capital Market - Live News